Franklin Resources’s Ginkgo Bioworks DNA Stock Holding History

Franklin Resources’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$166K	Buy	+16,773	New	+$140K	﹤0.01%	2891
2024 Q2	–	Sell	-653	Closed	-$30.3K	–	2893
2024 Q1	$30.3K	Buy	+653	New	+$33.8K	﹤0.01%	2790
2023 Q4	–	Sell	-365	Closed	-$26.4K	–	2656
2023 Q3	$26.4K	Buy	+365	New	+$29.2K	﹤0.01%	2576
2022 Q1	–	Sell	-112,503	Closed	-$37.4M	–	2460
2021 Q4	$37.4M	Sell	112,503 -101,250	-47%	-$48.1M	0.01%	727
2021 Q3	$99.1M	Buy	+213,753	New	+$104M	0.04%	475

Other funds holding DNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JMFC

J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Franklin Resources's DNA Position: Q2 2026 in Review

Franklin Resources opened a new position in Ginkgo Bioworks (DNA) in Q2 2026: 16,773 shares worth $166K. The stake represents ﹤0.01% of the portfolio and ranks #2891 among its holdings. This is a return to the name: Franklin Resources previously reported a position in DNA as recently as Q1 2024.

Franklin Resources first reported a position in DNA in Q3 2021 and has held it in 5 quarters since. The position peaked at $99.1M in Q3 2021. 184 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

Franklin Resources held 16,773 shares of Ginkgo Bioworks worth $166K as of Q2 2026.
Ginkgo Bioworks was a new Franklin Resources position in Q2 2026.
Ginkgo Bioworks made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #2891 holding.
Franklin Resources first reported a position in Ginkgo Bioworks in Q3 2021 and has held it in 5 quarters since.
Franklin Resources's Ginkgo Bioworks position peaked at $99.1M in Q3 2021.
184 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.